REQUEST A DEMO
Total
USD $0.00
Search more companies

Genesystem Co., Ltd (South Korea)

Main Activities: Electromedical and Electrotherapeutic Apparatus Manufacturing
Full name: Genesystem Co., Ltd Profile Updated: July 27, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

The company is a Korea-based company principally engaged in the development and manufacture of molecular diagnostic solutions. The Company is engaged in the development, manufacture and sale of platform based on molecular diagnosis. The Company develops and manufactures products such as molecular diagnosis systems, biochips, test kits, and reaction reagents, among others. The Company develops in vitro diagnostic technology through immunodiagnosis technology and molecular diagnosis technology. The Company was established on March 24, 2010. The Company share was listed on the Korea Securities Dealers Automated Quotation System ( KOSDAQ ) on May 26, 2021.

Headquarters
200-9, Techno 2-Ro, Yuseong-Gu
Daejeon; Daejeon;

Contact Details: Purchase the Genesystem Co., Ltd report to view the information.

Website: http://www.genesystem.co.kr

Basic Information
Total Employees:
Purchase the Genesystem Co., Ltd report to view the information.
Outstanding Shares:
Purchase the Genesystem Co., Ltd report to view the information.
Registered Capital:
Purchase the Genesystem Co., Ltd report to view the information.
Financial Auditors:
Purchase the Genesystem Co., Ltd report to view the information.
Incorporation Date:
March 24, 2010
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Subsidiaries
㈜진시스템
Company Performance
Financial values in the chart are available after Genesystem Co., Ltd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
-75.44%
Total operating revenue
-51.37%
Operating profit (EBIT)
-25.55%
EBITDA
-24.88%
Net Profit (Loss) for the Period
10.42%
Total assets
-5.48%
Total equity
-12.61%
Operating Profit Margin (ROS)
-790.44%
Net Profit Margin
-652.15%
Return on Equity (ROE)
-0.64%
Debt to Equity Ratio
2.97%
Quick Ratio
-6.49%
Cash Ratio
-4.83%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?